ORIC Pharmaceuticals Competitors and Similar CompaniesClear all

ORIC Pharmaceuticals's competitors and similar companies include Biomedix Group, Baudax Bio, TRPharm and Medexus Pharma.

	ORIC Pharmaceuticals ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer.	Biomedix Group Biomedix Group is a pharmaceutical company.	Baudax Bio Baudax Bio is a pharmaceutical company that focuses on developing and commercializing products for patients in acute care settings.	TRPharm TRPharm is an R&D based company offering alternatives in certain treatment areas for oncology, virology, inflammatory, and rare diseases.	Medexus Pharma Medexus Pharma is a pharmaceutical company.
Founding Date	Founding Date 2014	Founding Date N/A	Founding Date 2019	Founding Date 2013	Founding Date 2013
Type	Type Public	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma
Locations	Locations South San Francisco, US HQ San Diego, US	Locations Borehamwood, GB HQ	Locations Malvern, US HQ	Locations İstanbul, TR HQ Accra, GH Dubai, AE	Locations Chicago, US HQ Bolton, CA
Employees	Employees 57	Employees 13	Employees 20	Employees 98	Employees 98
Valuation ($)	Valuation ($) 634.9 m	Valuation ($) N/A	Valuation ($) 8.1 m	Valuation ($) N/A	Valuation ($) 45.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.3m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $108.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $7m (FY, 2022)	Cost of goods N/A	Cost of goods $44.8m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ($5.7m) (FY, 2022)	Gross profit N/A	Gross profit $63.5m (FY, 2025)
Net income	Net income ($129.5m) (FY, 2025)	Net income N/A	Net income ($58.8m) (FY, 2022)	Net income N/A	Net income $2.2m (FY, 2025)